Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

IGC Pharma, Inc. Common Stock (NY: IGC )

0.2991 -0.0147 (-4.68%)
Official Closing Price Updated: 8:00 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IGC Pharma, Inc. Common Stock

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
India Globalization Capital Appoints Claudia Grimaldi to its Board of Directors
From India Globalization Capital, Inc.
Via Business Wire
India Globalization Capital Posts Net Loss Of $2.38M For The Third Quarter
India Globalization Capital, Inc. (AMEX:IGC) announced its financial results for the three months ending December 31, 2021 – quarter three of the company’s 2022 fiscal year. Q3 Financial Highlights 
Via Benzinga
IGC Reports Financial Results for the December 31, 2021 Quarter
From India Globalization Capital, Inc.
Via Business Wire
India Globalization Capital Appoints Former Congressman Jim Moran to Its Board of Directors
From India Globalization Capital, Inc.
Via Business Wire
A Forgettable Week For Alzheimer's Treatment Stocks
Two of our top names that spiked last week come back down to earth. This is why we hedge. 
Via Talk Markets
Why India Globalization Capital Shares Spiked Today
India Globalization Capital (AMEX:IGC) shares are trading hig... 
Via Benzinga
IGC THC-Drug For Alzheimer's Symptoms Proved Safe & Effective, Pending FDA Approval For More Trials
India Globalization Capital, Inc. (NYSE: IGC) announced Tuesday that it had received positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a... 
Via Benzinga
Clinical Trial on Alzheimer’s Patients Indicates Positive Safety and Tolerability Data for IGC’s THC-Based Investigational New Drug
From India Globalization Capital, Inc.
Via Business Wire
IGC Trials Research Effective THC Drug Dosing For Alzheimer's Patients
India Globalization Capital, Inc. (AMEX:IGC) revealed th... 
Via Benzinga
Phase 1 Clinical Trial Provides Valuable Insights on Safe and Effective Dosing of IGC-AD1 for Alzheimer’s Patients
From India Globalization Capital, Inc.
Via Business Wire
Phase 1 Clinical Trial Data Indicate IGC’s THC-based Investigational New Drug May Reduce Symptoms of Dementia in Alzheimer’s Patients
From India Globalization Capital, Inc.
Via Business Wire
Potential Cannabis Unicorn "InterCure" Realizes the 7th Consecutive Quarter of Revenue Growth
Former prime minister of Israel and InterCure chairman Ehud Barak at the company’s market open from their cultivation site in Israel... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
IGC Posts Q2 Results, Reveals Promising Results From Clinical Trial Of THC-Drug For Alzheimer's Symptoms
India Globalization Capital, Inc. (AMEX: 
Via Benzinga
IGC Reports Financial Results for the September 30, 2021 Quarter
From India Globalization Capital, Inc.
Via Business Wire
IGC Announces Results of its 2021 Annual Stockholders Meeting
From India Globalization Capital, Inc.
Via Business Wire
21 Stocks Moving in Wednesday's Pre-Market Session
Gainers Kadmon Holdings, Inc. (NASDAQ: KDMN) rose 75.7% to $9.31 in pre-market trading after France's Sanofi announced plans to buy the company in a $1.9 billion deal. SPAR... 
Via Benzinga
IGC Completes its Phase 1 Clinical Trial on Alzheimer’s Patients, Reports Safety and Tolerability
From India Globalization Capital, Inc.
Via Business Wire
IGC Reports Financial Results for the June 30, 2021, Quarter
From India Globalization Capital, Inc.
Via Business Wire
A Forgettable Week For Alzheimer's Treatment Stocks: Two Of Our Top Names Come Back To Earth. This Is Why We Hedge.
Screen capture via Cassava Sciences' video for their Simufilam Alzheimer's disease treatment. Two Alzheimer's Names Come Back To Earth In a post last week (An... 
Via Benzinga
75 Biggest Movers From Friday
Gainers The New Home Company Inc. (NYSE: NWHM) jumped 82.9% to settle at $8.89 on Friday after the company agreed to be acquired by funds managed by affiliates of Apollo Global... 
Via Benzinga
An Unforgettable Week For Alzheimer's Treatment Stocks: Two Of Our Recent Top Names Spike On News Of Potentially Promising Treatments
Screen capture via IGC's healthcare subsidiary Hyalolex. "Drops of Clarity" is their just-patented Alzheimer's treatment. Two Stocks Spike On Alzheimer... 
Via Benzinga
50 Stocks Moving In Friday's Mid-Day Session
Gainers Xenetic Biosciences Inc (NASDAQ: XBIO) shares jumped 111.3% to $3.9299 on abnormally-high volume. The New Home Company Inc. (NYSE: NWHM) climbed 83% to $8.90 after the... 
Via Benzinga
An Unforgettable Week For Alzheimer's Treatment Stocks
Two of our recent top stocks spiked on news of potentially promising Alzheimer's treatments this week. They're both risky names, so we look at how to hold them without losing your shirt. 
Via Talk Markets
32 Stocks Moving in Friday's Pre-Market Session
Gainers Socket Mobile Inc (NASDAQ: SCKT) shares rose 100.2% to $11.61 in pre-market trading after the company reported better-than-expected Q2 results. Acorda Therapeutics Inc (... 
Via Benzinga
India Globalization Capital Shares Skyrocket On Receiving Patent For THC Formula To Treat Alzheimer's Disease
India Globalization Capital, Inc. (AMEX: IGC) revealed ... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
IGC Stock: The Huge Cannabis Patent News That Has IGC Flying High
IGC stock is moving up in a huge way today. The company is finally earning its patent for the treatment of Alzheimer's disease with cannabis. 
Via InvestorPlace
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property Product Safety
IGC Announces Issuance of Patent for the Treatment of Alzheimer’s Disease Using THC
From India Globalization Capital, Inc.
Via Business Wire
21 Stocks Moving in Monday's Pre-Market Session
Gainers Creatd Inc (NASDAQ: CRTD) shares rose 33.9% to $4.27 in pre-market trading after dropping around 9% on Friday. Oxbridge Re Holdings Ltd (NASDAQ: OXBR) shares rose 13.2%... 
Via Benzinga
Global Cannabis Stocks Decline 8.7% in Q2, Agrify, KushCo Among Strongest Cannabis Names In June
The Global Cannabis Stock Index fell for the fourth straight month, dropping 4.1% to 57.10. During the second quarter, the index was down... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
22 Stocks Moving in Tuesday's Pre-Market Session
Gainers Exela Technologies, Inc. (NASDAQ: XELA) rose 39% to $2.05 in pre-market trading after gaining over 5% on Monday. Marin Software Incorporated (NASDAQ: MRIN) rose 36.8% to... 
Via Benzinga
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.